CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

Slef questionnaires fulfilmentWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (0)

Name (Synonyms) Correlation

Correlated MeSH Terms (1)

Name (Synonyms) Correlation
D003863 Depression, NIH 0.15

Correlated HPO Terms (0)

Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials

1 Descriptive Study of the PSYchological Impact of CONFinement Measures in the General Population : PsyConfPop

Quarantine is an unpleasant experience : separation from loved ones, loss of freedom, uncertainty about infection status, boredom. It may lead to negative mental health consequences and thus the emergence of anxiety and depressive symptoms. From March 17th, 2020 to May 11th 2002, the French government has implemented national containment measures due to the Covid-19 epidemic. Although there are data on the psychological impact and experience of quarantine measures in people who have been infected or suspected of being carriers of certain pathogens (e.g. Ebola), there are no data on such impact in the French population and quarantines lasting longer than 21 days. Investigators therefore propose to conduct a human and social sciences study in order to better understand the current situation

NCT04374643 Depression COVID 19 Other: Slef questionnaires fulfilment
MeSH:Depression

Primary Outcomes

Description: depressive symptomatology with Patient Health Questionnaire : PHQ-9 scale (PHQ 9 higher score, more depressive —> min : 0 max : 27)

Measure: Depressive Symptomatology

Time: during confinement

Secondary Outcomes

Description: depressive symptomatology with Patient Health Questionnaire : PHQ-9 scale (PHQ 9 higher score, more depressive —> min : 0 max : 27)

Measure: Depressive Symptomatology

Time: post-confinement : 15 days, 3 months, 6 months

Other Outcomes

Description: Psychological pain : likert scale (higher score, more psychological pain—> min : 0 max : 10)

Measure: Psychological pain

Time: during confinement

Description: quality of sleep assessed with Insomnia Seveity Index (ISI Insomnia Severity Scale ; higher score, more insomnia —> min : 0 max : 28)

Measure: sleep

Time: during confinement

Description: quality of sleep assessed with Insomnia Seveity Index (ISI Insomnia Severity Scale ; higher score, more insomnia —> min : 0 max : 28)

Measure: sleep

Time: post-confinement (15 days, 3 months, 6 months)

Description: anxiety intensity assessed by Generalized Anxieety Disorder (GAD 7 Generalized Anxiety Disorder higher score, more anxious —> min : 0 max : 21)

Measure: anxiety

Time: during confinement

Description: anxiety intensity assessed by Generalized Anxieety Disorder (GAD 7 Generalized Anxiety Disorder higher score, more anxious —> min : 0 max : 21)

Measure: anxiety

Time: post-confinement (15 days, 3 months, 6 months)

Description: psychological pain : likert scale (higher score, more psychological pain—> min : 0 max : 10)

Measure: psychological pain

Time: post-confinement (15 days, 3 months, 6 months)

Description: psychological pain : likert scale (higher score, more psychological pain—> min : 0 max : 10)

Measure: physical pain

Time: during confinement

Description: psychological pain : likert scale higher score, more psychological pain—> min : 0 max : 10)

Measure: physical pain

Time: post-confinement (15 days, 3 months, 6 months)

Description: staxi state scale (STAXI ; State and Trait Anger Expression Inventory : higher score, more anger —> min : 0 max : 50)

Measure: anger

Time: during confinement

Description: staxi state scale (STAXI ; State and Trait Anger Expression Inventory : higher score, more anger —> min : 0 max : 50)

Measure: anger

Time: post-confinement (15 days, 3 months, 6 months)

Description: Assessed by the Stressful Event Impact Scale - Horowitz (HOROWITZ higher score, more traumatizes —> min : 0 max : 45) )

Measure: Stressful Event Impact

Time: during confinement

Description: Assessed by the Stressful Event Impact Scale - Horowitz (HOROWITZ higher score, more traumatizes —> min : 0 max : 45)

Measure: Stressful Event Impact

Time: post-confinement (15 days, 3 months, 6 months)

Description: Number of patients declaring an increase of psychotropic drug use

Measure: Use of psychotropic drugs

Time: during confinement

Description: Number of patients declaring an increase of psychotropic drug use

Measure: Use of psychotropic drugs

Time: post-confinement (15 days, 3 months, 6 months)

Description: Number of patients declaring an increase of tobacco consumption

Measure: Tobacco consumption

Time: during confinement

Description: Number of patients declaring an increase of tobacco consumption

Measure: Tobacco consumption

Time: post-confinement (15 days, 3 months, 6 months)

Description: Number of patients declaring an increase of alcohol consumption

Measure: alcohol consumption

Time: post-confinement (15 days, 3 months, 6 months)

Description: Number of patients declaring an increase of alcohol consumption

Measure: alcohol consumption

Time: confinement

Description: Number of patients declaring an increase of illicit substances consumption

Measure: Illicit substances consumption

Time: confinement

Description: Number of patients declaring an increase of illicit substances consumption

Measure: Illicit substances consumption

Time: post-confinement (15 days, 3 months, 6 months)

Description: Life Orinetation Test Revised (LOT-R questionnaire): higher score, more optimistic --> min : 0 max : 24

Measure: orientation of life

Time: confinement

Description: Life Orinetation Test Revised (LOT-R questionnaire): higher score, more optimistic --> min : 0 max : 24

Measure: orientation of life

Time: post-confinement (15 days, 3 months, 6 months)

No related HPO nodes (Using clinical trials)